1 August 2023 false Taxfiler 2024.6 14074369business:PrivateLimitedCompanyLtd2023-08-012024-07-31 140743692023-07-31 140743692023-08-012024-07-31 14074369business:AuditExemptWithAccountantsReport2023-08-012024-07-31 14074369business:FilletedAccounts2023-08-012024-07-31 140743692024-07-31 14074369business:Director12023-08-012024-07-31 14074369business:RegisteredOffice2023-08-012024-07-31 140743692023-07-31 14074369core:WithinOneYear2024-07-31 14074369core:WithinOneYear2023-07-31 14074369core:AfterOneYear2024-07-31 14074369core:AfterOneYear2023-07-31 14074369core:ShareCapitalcore:PreviouslyStatedAmount2024-07-31 14074369core:ShareCapitalcore:PreviouslyStatedAmount2023-07-31 14074369core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-07-31 14074369core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-07-31 14074369core:PreviouslyStatedAmount2024-07-31 14074369core:PreviouslyStatedAmount2023-07-31 14074369business:SmallEntities2023-08-012024-07-31 14074369countries:EnglandWales2023-08-012024-07-31 14074369core:FurnitureFittings2023-08-012024-07-31 14074369core:ComputerEquipment2023-08-012024-07-31 14074369core:Goodwill2023-07-31 14074369core:Goodwill2023-08-012024-07-31 14074369core:Goodwill2024-07-31 14074369core:FurnitureFittings2023-07-31 14074369core:ComputerEquipment2023-07-31 14074369core:FurnitureFittings2024-07-31 14074369core:ComputerEquipment2024-07-31 14074369business:OrdinaryShareClass12023-08-012024-07-31 14074369business:OrdinaryShareClass12022-04-272023-07-31 140743692022-04-272023-07-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 14074369 (England and Wales)
Vista Pharm Ltd Unaudited accounts for the year ended 31 July 2024
Vista Pharm Ltd Unaudited accounts Contents
Page
- 2 -
Vista Pharm Ltd Company Information for the year ended 31 July 2024
Director
Ishpal Rihal
Company Number
14074369 (England and Wales)
Registered Office
92 The Drive Isleworth Middlesex TW7 4AD England
Accountants
P10 Accountancy Ltd 77A Richmond Road Twickenham TW1 3AW
- 3 -
Vista Pharm Ltd Statement of financial position as at 31 July 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Intangible assets
617,688 
- 
Tangible assets
15,972 
3,431 
633,660 
3,431 
Current assets
Inventories
28,056 
- 
Debtors
236,852 
- 
Cash at bank and in hand
66,238 
184,663 
331,146 
184,663 
Creditors: amounts falling due within one year
(352,366)
(144,028)
Net current (liabilities)/assets
(21,220)
40,635 
Total assets less current liabilities
612,440 
44,066 
Creditors: amounts falling due after more than one year
(437,617)
- 
Net assets
174,823 
44,066 
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
174,822 
44,065 
Shareholders' funds
174,823 
44,066 
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 25 April 2025 and were signed on its behalf by
Ishpal Rihal Director Company Registration No. 14074369
- 4 -
Vista Pharm Ltd Notes to the Accounts for the year ended 31 July 2024
1
Statutory information
Vista Pharm Ltd is a private company, limited by shares, registered in England and Wales, registration number 14074369. The registered office is 92 The Drive, Isleworth, Middlesex, TW7 4AD, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
25% Straight Line
Computer equipment
25% Straight Line
Intangible fixed assets
Intangible fixed assets (including purchased goodwill) are included at cost less accumulated amortisation. The amortisation policy is 5% straight line.
Inventories
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Cash & cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
- 5 -
Vista Pharm Ltd Notes to the Accounts for the year ended 31 July 2024
Financial instruments
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
4
Intangible fixed assets
Goodwill 
£ 
Cost
At 1 August 2023
- 
Additions
650,198 
At 31 July 2024
650,198 
Amortisation
At 1 August 2023
- 
Charge for the year
32,510 
At 31 July 2024
32,510 
Net book value
At 31 July 2024
617,688 
5
Tangible fixed assets
Fixtures & fittings 
Computer equipment 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 August 2023
- 
4,575 
4,575 
Additions
16,743 
1,503 
18,246 
At 31 July 2024
16,743 
6,078 
22,821 
Depreciation
At 1 August 2023
- 
1,144 
1,144 
Charge for the year
4,186 
1,519 
5,705 
At 31 July 2024
4,186 
2,663 
6,849 
Net book value
At 31 July 2024
12,557 
3,415 
15,972 
At 31 July 2023
- 
3,431 
3,431 
- 6 -
Vista Pharm Ltd Notes to the Accounts for the year ended 31 July 2024
6
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
VAT
28,961 
- 
Trade debtors
7,932 
- 
Accrued income and prepayments
199,959 
- 
236,852 
- 
7
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Bank loans and overdrafts
19,865 
- 
Trade creditors
173,851 
- 
Taxes and social security
36,650 
9,210 
Other creditors
15,000 
14,000 
Loans from directors
106,743 
119,618 
Accruals
257 
1,200 
352,366 
144,028 
8
Creditors: amounts falling due after more than one year
2024 
2023 
£ 
£ 
Bank loans
437,617 
- 
9
Share capital
2024 
2023 
£ 
£ 
Allotted, called up and fully paid:
1 Ordinary shares of £1 each
1 
1 
10
Average number of employees
During the year the average number of employees was 5 (2023: 1).
- 7 -